Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Brac University
2023
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10361/18146 |
| id |
10361-18146 |
|---|---|
| record_format |
dspace |
| spelling |
10361-181462023-04-13T21:01:43Z Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status Tamanna, Mst. Taskia Sharmin, Dr. Sabrina Department of Pharmacy, Brac University Senile plaques Alzheimer’s disease Apolipoprotein E Bridging integrator 1 Drug development Alzheimer's disease--Treatment--Congresses. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. Cataloged from PDF version of thesis. Includes bibliographical references (pages 47-60). A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even though it is the leading motive of dementia in the modern era. The community of patients with AD leads to expansion. Anxiety, anger, and inappropriate behavior, as well as sleep difficulty and psychosis are frequent symptoms of Alzheimer's disease, which is characterized by cognitive decline but also by mood and behavioral symptoms. This study aims to assemble all probable bio-similar drugs of Alzheimer's disease that predict to help slow down the disease's development. In this study, we try to express the genetic factors, environmental factors and treatment associated bio-molecular drugs. Research articles, news stories, academic papers published in journals and government websites such as PubMed were used to conduct a comprehensive literature analysis on the development and availability of bio-similar drugs to treat AD. Alzheimer's disease affects an older population, making treatment more difficult. There is currently no medicine that can prevent or cure the condition. In order to improve public health, even a slight delay in the start ofsymptoms might have a significant influence. Studying prospective treatments for Alzheimer's disease as the illness's incidence rises is an ongoing process for researchers. Mst. Taskia Tamanna B. Pharmacy 2023-04-13T07:33:47Z 2023-04-13T07:33:47Z 2022 2022-04 Thesis ID: 17346008 http://hdl.handle.net/10361/18146 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 60 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Senile plaques Alzheimer’s disease Apolipoprotein E Bridging integrator 1 Drug development Alzheimer's disease--Treatment--Congresses. |
| spellingShingle |
Senile plaques Alzheimer’s disease Apolipoprotein E Bridging integrator 1 Drug development Alzheimer's disease--Treatment--Congresses. Tamanna, Mst. Taskia Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. |
| author2 |
Sharmin, Dr. Sabrina |
| author_facet |
Sharmin, Dr. Sabrina Tamanna, Mst. Taskia |
| format |
Thesis |
| author |
Tamanna, Mst. Taskia |
| author_sort |
Tamanna, Mst. Taskia |
| title |
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| title_short |
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| title_full |
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| title_fullStr |
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| title_full_unstemmed |
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status |
| title_sort |
bio-similar drug development and accessible drugs in the market for the treatment of alzheimer's disease: current status |
| publisher |
Brac University |
| publishDate |
2023 |
| url |
http://hdl.handle.net/10361/18146 |
| work_keys_str_mv |
AT tamannamsttaskia biosimilardrugdevelopmentandaccessibledrugsinthemarketforthetreatmentofalzheimersdiseasecurrentstatus |
| _version_ |
1814307733328887808 |